Home › Overweight › Tennessee › Knoxville

Pag-aaral pangklinika para sa Overweight sa Knoxville, TN

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Knoxville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3

New Phase Research and Development, Knoxville
Accellacare US Inc., d/b/a Accellacare of Knoxville, Knoxville

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3

Accellacare of Knoxville, Knoxville
Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell · 8 mi ang layo

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2

New Phase Research & Development /ID# 282131, Knoxville
Summit Medical Group- Halls Family Physicians /ID# 282435, Knoxville

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3

New Phase Research and Development, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3

Research Site, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Knoxville

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Nagre-recruitPhase 1

MBX Biosciences Investigational Site, Knoxville

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT07142707

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Knoxville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.